Grant & Eisenhofer is pursuing recoveries for states and municipalities for cancer risks tied to ranitidine (Zantac); partial settlements reached in two separate matters
Plaintiff(s):
State of New Mexico, City of Baltimore
Case type / claims:
Product liability and consumer protection actions seeking damages, restitution, and medical monitoring for cancer risks associated with ranitidine (Zantac), including Medicaid reimbursement and other publicly funded healthcare program losses.
Defendant(s):
GlaxoSmithKline LLC, Pfizer Inc., Sanofi, and other ranitidine manufacturers
Jurisdiction:
First Judicial District Court, Santa Fe County; U.S. District Court for the District of Maryland
Year:
2025; partial settlement
Outcome:
Partial confidential settlements.
